跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MB-40
首页
药物
MB-40
MB-40
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Radiolabeled tracers for poly (ADP-ribose) polymerase-1 (PARP-1), methods and uses therefor
US 9993570 B2
申请人: UNIV WASHINGTON
优先权: 2014
CN
US
2 件公开
顺铂纳米药物制剂、制备方法和应用
CN 108836937 B
申请人: 浙江大学
优先权: 2018
CN
Traditional Chinese medicine composition capable of inhibiting tumor metastasis and preparation method and application thereof
CN 109908302 A
申请人: GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE GUANGDONG PROVINCE TRADITIONAL CHINESE MEDICAL HO
优先权: 2019
CN
Application of ginkgolide composition in preparation of drugs for acute coronary syndrome
CN 110051664 A
申请人: JIANGSU KANION PHARMACEUTICAL CO LTD
优先权: 2019
CN
Use of 3,3′-diselenodipropionic acid (DSePA) as an anticancer agent
US 11213499 B1
申请人: SEC DEP OF ATOMIC ENERGY
优先权: 2020
US
一种高纯度硝普钠原料药的制备方法
CN 115893447 B
申请人: 安徽普利药业有限公司
优先权: 2022
CN
4-seleno-1-benzenesulfonyl pyrazole compound as well as electrochemical synthesis method and application thereof
CN 118184582 A
申请人: UNIV YANAN
优先权: 2024
CN
Method for treating AR negative TNBC through combination of quercetin and enzalutamide
CN 121796389 A
申请人: UNIV WUHAN SCIENCE & TECH
优先权: 2026
CN
药物
反馈